+91-22-45045900 sales@clearsynth.com
Global Scientific Solutions with Precision and Purpose
Recent Updates
New Nitrosamine Compounds Now Available
Now Operating in San Diego, USA
Stable Isotopes Product Detail
Home Stable Isotopes Palbociclib CS-O-15447

Palbociclib-d8

Explore technical data, documentation access, molecular information and enquiry options for this Clearsynth research product.

Product Code: CS-O-15447 Stable Isotopes Research Use Only
Palbociclib-d8
Category
Stable Isotopes
API Family
Palbociclib
Product Code
CS-O-15447
Research Status
For Laboratory Use

Palbociclib-d8

Palbociclib Stable Isotopes
Stock Status: In Stock
Live

CAT No.
CS-O-15447
CAS No.
1628752-83-9
Molecular Formula
C₂₄H₂₁D₈N₇O₂
Molecular Weight
455.58
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal or Veterinary use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
1628752-83-9
Product Code
CS-O-15447
M.F.
C₂₄H₂₁D₈N₇O₂
M.W.
455.58
Smiles
O=C1C(C(C)=O)=C(C)C2=CN=C(NC3=NC=C(N4C([2H])([2H])C([2H])([2H])NC([2H])([2H])C4([2H])[2H])C=C3)N=C2N1C5CCCC5
Category
Stable Isotopes
API Family
Palbociclib
Storage Condition
Store at refrigerator (2-8°C) for long term storage
IUPAC Name
6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(2,2,3,3,5,5,6,6-octadeuteriopiperazin-1-yl)pyridin-2- yl]amino]pyrido[2,3-d]pyrimidin-7-one
References
"Finn; R,; et al,: Breast Cancer Res,; 11; 5 (2009)"
Synonyms
Not available
Application Notes
"Palbociclib-d8 is labelled Palbociclib, an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6."
Purity by HPLC
Not less than 90%
Hazard Compound
Refer MSDS for accurate information.
Overview
"Palbociclib-d8 is labelled Palbociclib, an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6."

Customers Also Viewed

Palbociclib Piperazine N-Oxide

Palbociclib Piperazine N-Oxide

CAT No: CS-P-01931
CAS No: 2174002-29-8
Palbociclib Impurity 19

Palbociclib Impurity 19

CAT No: CS-EO-00156
CAS No: 2205035-04-5
Palbociclib Impurity 32

Palbociclib Impurity 32

CAT No: CS-EO-01393
CAS No: NA
Palbociclib Impurity-G

Palbociclib Impurity-G

CAT No: CS-O-45791
CAS No: NA
Palbociclib Impurity 39

Palbociclib Impurity 39

CAT No: CS-O-39716
CAS No: 2363172-64-7
Palbociclib Impurity 9

Palbociclib Impurity 9

CAT No: CS-EO-00248
CAS No: 2204368-66-9
Tert-butyl 4-(4-aminopyridin-3-yl)

Tert-butyl 4-(4-aminopyridin-3-yl)

CAT No: CS-O-40315
CAS No: 1023594-50-4
Palbociclib Nitroso Impurity 3

Palbociclib Nitroso Impurity 3

CAT No: CS-O-59889
 N-Nitroso Palbociclib Impurity

N-Nitroso Palbociclib Impurity

CAT No: CS-O-52254
 Palbociclib Impurity 22

Palbociclib Impurity 22

CAT No: CS-O-33725
CAS No: 1922954-32-2

Refund Policy

We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of material handover. We have invested in the highest quality packaging materials and use international logistics partners to service our customers. If there is an issue with one or more of our products, it must be reported to us within 45 days of your receiving shipment for refund or account credit eligibility.

Downloading MSDS…
Quick Enquiry Email Us
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.